Fergal C. Kelleher

2.5k total citations
37 papers, 1.1k citations indexed

About

Fergal C. Kelleher is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fergal C. Kelleher has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fergal C. Kelleher's work include Melanoma and MAPK Pathways (5 papers), Hedgehog Signaling Pathway Studies (5 papers) and Cutaneous Melanoma Detection and Management (4 papers). Fergal C. Kelleher is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Hedgehog Signaling Pathway Studies (5 papers) and Cutaneous Melanoma Detection and Management (4 papers). Fergal C. Kelleher collaborates with scholars based in Ireland, Australia and New Zealand. Fergal C. Kelleher's co-authors include Hazel O’Sullivan, Aparna D. Rao, Anne Maguire, Ray McDermott, D. Fennelly, Máirín Rafferty, Grant A. McArthur, David M. Thomas, Elizabeth Smyth and John Crown and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Fergal C. Kelleher

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fergal C. Kelleher Ireland	14	616	325	214	195	135	37	1.1k
Wolf‐K. Hofmann Germany	18	770 1.3×	278 0.9×	144 0.7×	101 0.5×	109 0.8×	25	1.7k
Mansoor Ahmed United States	14	308 0.5×	222 0.7×	86 0.4×	193 1.0×	73 0.5×	37	761
Ryuichi Kanai Japan	17	399 0.6×	365 1.1×	83 0.4×	102 0.5×	56 0.4×	28	958
Kai Yu United States	16	671 1.1×	183 0.6×	228 1.1×	131 0.7×	27 0.2×	42	1.2k
Takeshi Namiki Japan	13	460 0.7×	194 0.6×	134 0.6×	129 0.7×	21 0.2×	58	1.0k
Paul D. Lira United States	9	324 0.5×	290 0.9×	153 0.7×	85 0.4×	84 0.6×	14	1.2k
Mary B. Breslin United States	20	553 0.9×	333 1.0×	122 0.6×	54 0.3×	36 0.3×	37	1.3k
Allison C. Sharrow United States	12	559 0.9×	238 0.7×	110 0.5×	60 0.3×	27 0.2×	16	1.0k
Yume T. Phung United States	9	486 0.8×	337 1.0×	71 0.3×	149 0.8×	22 0.2×	12	1.1k

Countries citing papers authored by Fergal C. Kelleher

Since Specialization

Citations

This map shows the geographic impact of Fergal C. Kelleher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fergal C. Kelleher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fergal C. Kelleher more than expected).

Fields of papers citing papers by Fergal C. Kelleher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fergal C. Kelleher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fergal C. Kelleher. The network helps show where Fergal C. Kelleher may publish in the future.

Co-authorship network of co-authors of Fergal C. Kelleher

This figure shows the co-authorship network connecting the top 25 collaborators of Fergal C. Kelleher. A scholar is included among the top collaborators of Fergal C. Kelleher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fergal C. Kelleher. Fergal C. Kelleher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crealey, Grainne, et al.. (2023). Melanoma-related costs by disease stage and phase of management in Ireland. Journal of Public Health. 45(3). 714–722. 9 indexed citations

Kelleher, Fergal C., et al.. (2021). Neo-adjuvant Vismodegib followed by radiation in locally advanced basal cell carcinoma. Current Problems in Cancer. 45(6). 100736–100736. 3 indexed citations

Mullally, William, Michael J. Kennedy, Dearbhaile M. O’Donnell, et al.. (2021). 1595P Acceptance of COVID-19 vaccination among cancer patients in an Irish cancer centre. Annals of Oncology. 32. S1144–S1145. 3 indexed citations

Alexander, Michael, et al.. (2020). Ifosfamide-induced encephalopathy: the EEG with frontal intermittent delta activity, and rapid resolution with methylene blue: A case report. PubMed. 10(1). 25–25. 6 indexed citations

Regan, Julie, Stephen P. Higgins, Norma O’Leary, et al.. (2019). Dysphagia Prevalence and Predictors in Cancers Outside the Head, Neck, and Upper Gastrointestinal Tract. Journal of Pain and Symptom Management. 58(6). 949–958.e2. 24 indexed citations

Kelleher, Fergal C. & Hazel O’Sullivan. (2017). Monocytes, Macrophages, and Osteoclasts in Osteosarcoma. Journal of Adolescent and Young Adult Oncology. 6(3). 396–405. 57 indexed citations

Kelleher, Fergal C., et al.. (2017). BRAF inhibitor treatment of melanoma causing colonic polyps: An alternative hypothesis. World Journal of Gastroenterology. 23(17). 3022–3022. 1 indexed citations

O'SULLIVAN, DERMOT A., Paul Dowling, Helena Joyce, et al.. (2017). A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer. British Journal of Cancer. 117(9). 1326–1335. 21 indexed citations

Kelleher, Fergal C., Aparna D. Rao, & Anne Maguire. (2013). Circadian molecular clocks and cancer. Cancer Letters. 342(1). 9–18. 196 indexed citations

10.

Kelleher, Fergal C., et al.. (2013). Fibroblast growth factor receptors, developmental corruption and malignant disease. Carcinogenesis. 34(10). 2198–2205. 106 indexed citations

11.

Kelleher, Fergal C., et al.. (2012). Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma. Pharmacology & Therapeutics. 136(2). 153–168. 34 indexed citations

12.

Kelleher, Fergal C. & Grant A. McArthur. (2012). Targeting NRAS in Melanoma. The Cancer Journal. 18(2). 132–136. 54 indexed citations

13.

Kelleher, Fergal C. & David M. Thomas. (2012). Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours. PubMed. 2(1). 6–6. 30 indexed citations

14.

Kelleher, Fergal C. & Ray McDermott. (2012). Aberrations and Therapeutics Involving the Developmental Pathway Hedgehog in Pancreatic cancer. Vitamins and hormones. 88. 355–378. 5 indexed citations

15.

Rani, Sweta, Keith O’Brien, Fergal C. Kelleher, et al.. (2011). Isolation of Exosomes for Subsequent mRNA, MicroRNA, and Protein Profiling. Methods in molecular biology. 784. 181–195. 93 indexed citations

16.

Collins, Ian, et al.. (2011). Clinical Decision Aids in Colon Cancer: A Comparison of Two Predictive Nomograms. Clinical Colorectal Cancer. 11(2). 138–142. 9 indexed citations

17.

Kelleher, Fergal C.. (2010). Hedgehog signaling and therapeutics in pancreatic cancer. Carcinogenesis. 32(4). 445–451. 99 indexed citations

18.

Kelleher, Fergal C. & Ray McDermott. (2010). The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene. European Journal of Cancer. 46(13). 2357–2368. 51 indexed citations

19.

Kelleher, Fergal C., et al.. (2007). A Potential Anatomic Cause of Mandibular Osteonecrosis in Patients Receiving Bisphosphonate Treatment. Mayo Clinic Proceedings. 82(1). 134–134. 1 indexed citations

20.

Kelleher, Fergal C., D. Fennelly, & Máirín Rafferty. (2006). Common critical pathways in embryogenesis and cancer. Acta Oncologica. 45(4). 375–388. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact